166 related articles for article (PubMed ID: 9560282)
1. Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines.
Missale C; Codignola A; Sigala S; Finardi A; Paez-Pereda M; Sher E; Spano PF
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5366-71. PubMed ID: 9560282
[TBL] [Abstract][Full Text] [Related]
2. Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation.
Fiorentini C; Facchetti M; Finardi A; Sigala S; Páez-Pereda M; Sher E; Spano P; Missale C
Eur J Endocrinol; 2002 Sep; 147(3):371-9. PubMed ID: 12213675
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
[TBL] [Abstract][Full Text] [Related]
4. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor suppresses the transforming phenotype of human prolactinomas.
Missale C; Boroni F; Losa M; Giovanelli M; Zanellato A; Dal Toso R; Balsari A; Spano P
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7961-5. PubMed ID: 8367448
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism.
Missale C; Losa M; Sigala S; Balsari A; Giovanelli M; Spano PF
Mol Endocrinol; 1996 Mar; 10(3):272-85. PubMed ID: 8833656
[TBL] [Abstract][Full Text] [Related]
7. The neurotoxin 1-methyl-4-phenylpyridinium: a selective cytostatic agent in small-cell lung cancer cell lines with neuroendocrine properties.
Marini AM; Fridman R; Kanemoto T; Martin GR; Guo Y; Passaniti A
J Natl Cancer Inst; 1992 Oct; 84(20):1582-7. PubMed ID: 1328660
[TBL] [Abstract][Full Text] [Related]
8. Transient exposure to cytarabine increases peptide growth factor receptor expression and tumorigenicity of melanoma cells.
Caraglia M; Leardi AI; Improta S; Perin V; Ricciardi B; Arra C; Ferraro P; Fabbrocini A; Pinto A; Bianco AR; Tagliaferri P
Anticancer Res; 1997; 17(4A):2369-75. PubMed ID: 9252649
[TBL] [Abstract][Full Text] [Related]
9. Effect of serotonin and nicotine on the growth of a human small cell lung cancer xenograft.
Pratesi G; Cervi S; Balsari A; Bondiolotti G; Vicentini LM
Anticancer Res; 1996; 16(6B):3615-9. PubMed ID: 9042230
[TBL] [Abstract][Full Text] [Related]
10. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.
Fridman R; Giaccone G; Kanemoto T; Martin GR; Gazdar AF; Mulshine JL
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6698-702. PubMed ID: 2168554
[TBL] [Abstract][Full Text] [Related]
11. CAI inhibits the growth of small cell lung cancer cells.
Moody TW; Chiles J; Moody E; Sieczkiewicz GJ; Kohn EC
Lung Cancer; 2003 Mar; 39(3):279-88. PubMed ID: 12609566
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule.
Scheidegger EP; Lackie PM; Papay J; Roth J
Lab Invest; 1994 Jan; 70(1):95-106. PubMed ID: 8302024
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract][Full Text] [Related]
16. Neurotrophin system activation in pleural effusions.
Ricci A; Mariotta S; Pompili E; Mancini R; Bronzetti E; De Vitis C; Pisani L; Cherubini E; Bruno P; Gencarelli G; Giovagnoli MR; Terzano C; Ciliberto G; Giarnieri E; Fumagalli L
Growth Factors; 2010 Aug; 28(4):221-31. PubMed ID: 20214505
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.
Arvelo F; Poupon MF; Le Chevalier T
Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823
[TBL] [Abstract][Full Text] [Related]
19. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effect of human interleukin-4 in human cancer cell lines: studies on the mechanism.
Topp MS; Papadimitriou CA; Eitelbach F; Oelmann E; Koehler B; Oberberg D; Von Marschall Z; Reufi B; Stein H; Thiel E
Leuk Lymphoma; 1995 Oct; 19(3-4):319-28. PubMed ID: 8535226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
